News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
442,325 Results
Type
Article (26153)
Company Profile (66)
Press Release (416106)
Multimedia
Podcasts (43)
Webinars (8)
Section
Business (114517)
Career Advice (778)
Deals (21191)
Drug Delivery (50)
Drug Development (76081)
Employer Resources (59)
FDA (11979)
Job Trends (9692)
News (222888)
Policy (19969)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (3)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
Academia (1536)
Accelerated approval (6)
Adcomms (28)
Allergies (73)
Alliances (32884)
ALS (91)
Alzheimer's disease (1303)
Antibody-drug conjugate (ADC) (116)
Approvals (11973)
Artificial intelligence (254)
Autoimmune disease (23)
Automation (15)
Bankruptcy (170)
Best Places to Work (8440)
BIOSECURE Act (14)
Biosimilars (55)
Biotechnology (51)
Bladder cancer (66)
Brain cancer (29)
Breast cancer (256)
Cancer (1957)
Cardiovascular disease (159)
Career advice (674)
Career pathing (15)
CAR-T (131)
Cell therapy (360)
Cervical cancer (18)
Clinical research (64229)
Collaboration (671)
Compensation (223)
Complete response letters (20)
COVID-19 (2147)
CRISPR (34)
C-suite (160)
Cystic fibrosis (70)
Data (1901)
Decentralized trials (2)
Denatured (16)
Depression (38)
Diabetes (209)
Diagnostics (4502)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (25)
Drug discovery (110)
Drug pricing (43)
Drug shortages (7)
Duchenne muscular dystrophy (83)
Earnings (45137)
Editorial (23)
Employer branding (2)
Employer resources (56)
Events (65861)
Executive appointments (526)
FDA (13060)
Featured Employer (20)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (611)
Gene editing (89)
Generative AI (23)
Gene therapy (262)
GLP-1 (595)
Government (2516)
Grass and pollen (4)
Guidances (39)
Healthcare (12567)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (101)
Indications (26)
Infectious disease (2262)
Inflammatory bowel disease (101)
Inflation Reduction Act (4)
Influenza (41)
Intellectual property (73)
Interviews (136)
IPO (10294)
IRA (18)
Job creations (1631)
Job search strategy (567)
Kidney cancer (11)
Labor market (7)
Layoffs (315)
Leadership (7)
Legal (3801)
Liver cancer (61)
Lung cancer (303)
Lymphoma (133)
Machine learning (5)
Management (22)
Manufacturing (222)
MASH (67)
Medical device (9784)
Medtech (9788)
Mergers & acquisitions (11368)
Metabolic disorders (564)
Multiple sclerosis (75)
NASH (19)
Neurodegenerative disease (87)
Neuropsychiatric disorders (27)
Neuroscience (1788)
NextGen: Class of 2025 (4118)
Non-profit (2335)
Northern California (2066)
Now hiring (9)
Obesity (289)
Opinion (156)
Ovarian cancer (71)
Pain (81)
Pancreatic cancer (71)
Parkinson's disease (137)
Partnered (13)
Patents (173)
Patient recruitment (104)
Peanut (42)
People (31057)
Pharmaceutical (15)
Pharmacy benefit managers (5)
Phase I (20040)
Phase II (28496)
Phase III (21523)
Pipeline (1038)
Policy (60)
Postmarket research (2011)
Preclinical (5890)
Press Release (33)
Prostate cancer (95)
Psychedelics (33)
Radiopharmaceuticals (222)
Rare diseases (320)
Real estate (2934)
Recruiting (16)
Regulatory (15391)
Reports (24)
Research institute (1670)
Resumes & cover letters (114)
Rett syndrome (4)
RNA editing (4)
RSV (33)
Schizophrenia (66)
Series A (101)
Series B (75)
Service/supplier (10)
Sickle cell disease (35)
Southern California (1768)
Special edition (7)
Spinal muscular atrophy (137)
Sponsored (25)
Startups (2059)
State (1)
Stomach cancer (10)
Supply chain (49)
Tariffs (6)
The Weekly (27)
United States (17626)
Vaccines (566)
Venture capitalists (21)
Weight loss (178)
Women's health (29)
Worklife (7)
Date
Today (122)
Last 7 days (464)
Last 30 days (1965)
Last 365 days (26949)
2025 (8215)
2024 (28248)
2023 (31445)
2022 (40213)
2021 (42404)
2020 (39364)
2019 (31585)
2018 (23583)
2017 (22757)
2016 (20506)
2015 (24014)
2014 (16990)
2013 (13472)
2012 (14207)
2011 (14491)
2010 (13236)
Location
Africa (433)
Alabama (43)
Alaska (5)
Arizona (108)
Arkansas (9)
Asia (27090)
Australia (5078)
California (4650)
Canada (1389)
China (415)
Colorado (204)
Connecticut (212)
Delaware (135)
Europe (61098)
Florida (693)
Georgia (189)
Idaho (46)
Illinois (350)
India (18)
Indiana (274)
Iowa (6)
Japan (133)
Kansas (59)
Kentucky (20)
Louisiana (6)
Maine (35)
Maryland (611)
Massachusetts (3413)
Michigan (180)
Minnesota (294)
Mississippi (2)
Missouri (74)
Montana (29)
Nebraska (16)
Nevada (46)
New Hampshire (56)
New Jersey (1351)
New Mexico (23)
New York (1384)
North Carolina (767)
North Dakota (7)
Northern California (2066)
Ohio (177)
Oklahoma (9)
Oregon (28)
Pennsylvania (1054)
Puerto Rico (9)
Rhode Island (21)
South America (579)
South Carolina (19)
South Dakota (1)
Southern California (1768)
Tennessee (80)
Texas (693)
Utah (116)
Virginia (105)
Washington D.C. (42)
Washington State (464)
West Virginia (2)
Wisconsin (50)
442,325 Results for "trial by fire solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Government
Appeals Court Stops Rehiring of Fired Federal Workers, Including From HHS
The Fourth Circuit’s ruling follows a Supreme Court verdict that also allowed the Trump administration to move forward with its mass layoffs at federal agencies.
April 10, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Senate Democrats Demand Return of Fired CDC Staff:
Reuters
Democratic senators from Georgia, Oregon, Maryland and New Mexico called the Trump administration’s decision to terminate hundreds of CDC staffers reckless and unfair.
March 20, 2025
·
2 min read
·
Tristan Manalac
Government
FDA to Rehire Scientists After Trump’s Firing Spree: Reuters
Around 300 FDA staffers laid off last week are being asked to return. So far, the Trump administration has terminated some 1,000 employees from the agency.
February 24, 2025
·
2 min read
·
Tristan Manalac
Podcast
FDA on Fire, Novo’s Mixed Bag of Semaglutide Cardio Data, Kisunla’s EU Miss, More
Biopharma leaders react to the forced resignation of CBER Head Peter Marks as RFK Jr.’s promised job cuts begin at the FDA; Novo Nordisk presents mixed results from oral semaglutide in cardiovascular disease; the EU’s Committee for Medicinal Products for Human Use declines to recommend Eli Lilly’s Alzheimer’s drug; and pharma R&D returns grew in 2024.
April 2, 2025
·
1 min read
·
Heather McKenzie
Press Releases
FIRE1 Secures $120 Million Financing to Revolutionize Heart Failure Care
January 7, 2025
·
3 min read
Press Releases
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
A growing body of clinical evidence supports the use of Firefly’s FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementia
March 6, 2025
·
10 min read
Press Releases
Agitated Solutions Receives IND Clearance from FDA to Initiate Phase 3 Clinical Trial of a Novel Contrast Agent
April 8, 2025
·
2 min read
Regulatory
Deep Dive: FDA’s Accelerated Approval Pathway Under Fire
In this deep dive
BioSpace
explores the opportunities and challenges presented by the FDA’s accelerated approval program.
November 18, 2024
·
2 min read
·
Heather McKenzie
Press Releases
Advarra Introduces Comprehensive Solution to Accelerate Study Startup and Improve Collaboration on Clinical Trials
January 21, 2025
·
4 min read
Press Releases
U.S. AI-based Clinical Trials Solution Provider Market Size to Reach USD 6.89 Bn By 2034
February 26, 2025
·
1 min read
1 of 44,233
Next